KR101249865B1 - 인돌린 화합물 및 그 제조방법 - Google Patents

인돌린 화합물 및 그 제조방법 Download PDF

Info

Publication number
KR101249865B1
KR101249865B1 KR1020077011689A KR20077011689A KR101249865B1 KR 101249865 B1 KR101249865 B1 KR 101249865B1 KR 1020077011689 A KR1020077011689 A KR 1020077011689A KR 20077011689 A KR20077011689 A KR 20077011689A KR 101249865 B1 KR101249865 B1 KR 101249865B1
Authority
KR
South Korea
Prior art keywords
phenoxy
ethyl
propyl
dihydro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077011689A
Other languages
English (en)
Korean (ko)
Other versions
KR20070084499A (ko
Inventor
도시아키 야마구치
이쿠오 츠치야
켄 기쿠치
다카시 야나기
Original Assignee
깃세이 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 깃세이 야쿠힌 고교 가부시키가이샤 filed Critical 깃세이 야쿠힌 고교 가부시키가이샤
Publication of KR20070084499A publication Critical patent/KR20070084499A/ko
Application granted granted Critical
Publication of KR101249865B1 publication Critical patent/KR101249865B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020077011689A 2004-10-27 2005-10-24 인돌린 화합물 및 그 제조방법 Expired - Lifetime KR101249865B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2004-00313040 2004-10-27
JP2004313040 2004-10-27
PCT/JP2005/019478 WO2006046499A1 (ja) 2004-10-27 2005-10-24 インドリン化合物およびその製造方法

Publications (2)

Publication Number Publication Date
KR20070084499A KR20070084499A (ko) 2007-08-24
KR101249865B1 true KR101249865B1 (ko) 2013-04-02

Family

ID=36227738

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011689A Expired - Lifetime KR101249865B1 (ko) 2004-10-27 2005-10-24 인돌린 화합물 및 그 제조방법

Country Status (17)

Country Link
US (1) US7834193B2 (enExample)
EP (1) EP1806340B1 (enExample)
JP (1) JP5049013B2 (enExample)
KR (1) KR101249865B1 (enExample)
CN (1) CN101048376B (enExample)
AT (1) ATE508113T1 (enExample)
AU (1) AU2005298078B2 (enExample)
BR (1) BRPI0517515B8 (enExample)
CA (1) CA2583660C (enExample)
DE (1) DE602005027881D1 (enExample)
ES (1) ES2362788T3 (enExample)
IL (1) IL182642A (enExample)
MX (1) MX2007005126A (enExample)
RU (1) RU2379289C2 (enExample)
TW (1) TW200621709A (enExample)
WO (1) WO2006046499A1 (enExample)
ZA (1) ZA200703996B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015126076A1 (ko) * 2014-02-20 2015-08-27 한미정밀화학주식회사 실로도신 제조에 사용되는 신규 중간체, 이의 제조방법 및 이를 이용한 실로도신의 제조방법
KR20190016208A (ko) * 2017-08-08 2019-02-18 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
US8013007B2 (en) 2007-02-26 2011-09-06 Concert Pharmaceuticals, Inc. Alpha 1A-adrenoceptor antagonists
MX2009009230A (es) * 2007-02-28 2009-11-26 Kissei Pharmaceutical Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna.
CN101585798B (zh) * 2008-05-20 2011-06-15 浙江华海药业股份有限公司 光学活性化合物1-(3-苯甲酰氧基丙基)-5-(2-(1-苯基乙基胺)丙基)-7-氰基吲哚啉及其制备方法和用途
CN101993405B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 吲哚啉衍生物、及其制备方法和用途
CN101993406B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 光学活性的吲哚啉化合物及其制备方法
CN101993407B (zh) * 2009-08-27 2014-01-29 浙江华海药业股份有限公司 用于制备西洛多辛的吲哚啉化合物及其制备方法
JP5661773B2 (ja) * 2009-09-12 2015-01-28 サンド・アクチエンゲゼルシヤフト インドリン誘導体の調製方法およびこれらの中間体
CN101768056B (zh) * 2010-01-19 2013-10-16 扬子江药业集团有限公司 一种取代的苯基甲基醚的制备方法
WO2011101864A1 (en) 2010-02-17 2011-08-25 Panacea Biotec Ltd Novel process for the synthesis of phenoxyethyl derivatives
WO2011124704A1 (en) 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
CN102311319A (zh) * 2010-07-05 2012-01-11 浙江华海药业股份有限公司 一种制备2-(2,2,2-三氟乙基)苯甲醚的方法
WO2012014186A1 (en) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates
CN102229557B (zh) * 2010-08-05 2013-03-27 南京海纳医药科技有限公司 西洛多辛的半水合物晶体、制备方法和包含它的药物组合物
CN102229558B (zh) * 2010-08-05 2013-05-08 南京海纳医药科技有限公司 西洛多辛的晶型δ、它的制备方法和包含它的药物组合物
CZ303060B6 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
CZ2010837A3 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
WO2012062229A1 (en) 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide
WO2012131710A2 (en) * 2011-03-30 2012-10-04 Panacea Biotec Ltd Novel process for the synthesis of indoline derivatives
WO2012147019A1 (en) * 2011-04-26 2012-11-01 Orchid Chemicals And Pharamceuticals Limited An improved process for the preparation of silodosin
WO2012147107A2 (en) * 2011-04-29 2012-11-01 Msn Laboratories Limited Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition
CN102382029B (zh) * 2011-07-26 2016-06-29 浙江华海药业股份有限公司 一种西洛多辛中间体成盐制备方法
WO2013072935A2 (en) 2011-10-10 2013-05-23 Cadila Healthcare Limited Process for the preparation of silodosin
EP2768806B1 (en) 2011-10-21 2017-05-31 Sandoz AG Method for preparing silodosin
CN102675182B (zh) * 2012-05-24 2014-03-26 临海天宇药业有限公司 1-(3-苯甲酰氧基丙基)-5-(2-羰基丙基)-7-腈基吲哚啉的制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
CN103159664B (zh) * 2013-03-29 2016-03-23 深圳市海滨制药有限公司 一种赛洛多辛原料药及其制备方法、药物组合物
CN104140389A (zh) * 2013-05-06 2014-11-12 昆明积大制药股份有限公司 一种赛洛多辛及其中间体的制备方法
CN103420893B (zh) * 2013-08-02 2015-11-25 江苏和成新材料有限公司 制备西洛多辛中间体的方法
JP6225998B2 (ja) * 2014-02-06 2017-11-08 宇部興産株式会社 インドリン化合物の製造方法
KR20150127996A (ko) * 2014-05-08 2015-11-18 한미정밀화학주식회사 실로도신 감마형 결정의 제조방법
JP6242298B2 (ja) * 2014-06-13 2017-12-06 株式会社トクヤマ １−（３−ベンゾイルオキシプロピル）−７−シアノ−５−［（２ｒ）−２−（｛２−［２−（２，２，２−トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］インドリンまたはその塩を製造する方法
KR101628946B1 (ko) * 2014-07-09 2016-06-09 동방에프티엘(주) 실로도신의 개선된 제조방법
KR101725393B1 (ko) 2014-07-24 2017-04-27 주식회사 경보제약 실로도신의 제조 방법 및 신규 중간체
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
JP2016088847A (ja) * 2014-10-30 2016-05-23 株式会社トクヤマ （‐）‐１‐（３‐ヒドロキシプロピル）‐５‐［［（２ｒ）‐２‐（｛２‐［２‐（２，２，２‐トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］‐２，３‐ジヒドロ‐１ｈ‐インドール‐７‐カルボキサミド］）の製造方法
CN104478784B (zh) * 2014-11-17 2017-02-22 武汉工程大学 一种西洛多辛草酸盐的晶型及其制备方法
KR101694262B1 (ko) * 2014-12-18 2017-01-10 (주)다산메디켐 실로도신의 결정형의 제조방법
US9356405B1 (en) 2015-03-05 2016-05-31 Sony Corporation Connector tongue element for an electrical connector plug receptacle and a method for producing the same
RU2018114512A (ru) * 2015-09-23 2019-10-23 Биокон Лимитед Способ получения соединений индолина и новая соль индолина
BR112018005934A2 (pt) 2015-09-23 2018-10-09 Biocon Ltd formas cristalinas de intermediário de posaconazol e processo para a preparação de posaconazol amorfo
ES2607639B1 (es) 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina
CN106995399A (zh) * 2016-01-25 2017-08-01 北京天泰恒华医药技术有限公司 一种制备赛洛多辛的方法
KR102163068B1 (ko) * 2018-07-04 2020-10-07 주식회사 가피바이오 실로도신 합성용 중간체의 제조 방법 및 이를 이용한 실로도신의 제조 방법
CN111217735B (zh) * 2018-11-27 2023-03-14 上海汇伦医药股份有限公司 赛洛多辛中间体的制备方法
WO2020237645A1 (zh) * 2019-05-31 2020-12-03 上海汇伦生命科技有限公司 赛洛多辛中间体的制备方法
CN110452149B (zh) * 2019-06-13 2021-11-02 北京鑫开元医药科技有限公司 二氢吲哚化合物的制备方法、二氢吲哚化合物及用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001199956A (ja) * 2000-01-14 2001-07-24 Kissei Pharmaceut Co Ltd 光学活性なインドリン誘導体の製造方法およびその製造中間体
JP2002265444A (ja) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.
EP0600675B1 (en) 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
JP3419539B2 (ja) * 1993-02-17 2003-06-23 中外製薬株式会社 インドリン−２−オン誘導体
JP3331047B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドリン誘導体
JP2526811B2 (ja) * 1994-07-22 1996-08-21 田辺製薬株式会社 フェネチルアミン誘導体及びその製法
RU2212404C2 (ru) * 1998-02-27 2003-09-20 Киссеи Фармасьютикал Ко., Лтд. Производные индола и фармацевтические композиции, включающие их
JP2006188470A (ja) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd インドリン誘導体およびその製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001199956A (ja) * 2000-01-14 2001-07-24 Kissei Pharmaceut Co Ltd 光学活性なインドリン誘導体の製造方法およびその製造中間体
JP2002265444A (ja) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015126076A1 (ko) * 2014-02-20 2015-08-27 한미정밀화학주식회사 실로도신 제조에 사용되는 신규 중간체, 이의 제조방법 및 이를 이용한 실로도신의 제조방법
KR20190016208A (ko) * 2017-08-08 2019-02-18 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법
KR102365411B1 (ko) 2017-08-08 2022-02-21 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법

Also Published As

Publication number Publication date
US7834193B2 (en) 2010-11-16
AU2005298078A1 (en) 2006-05-04
TWI356819B (enExample) 2012-01-21
CN101048376A (zh) 2007-10-03
BRPI0517515A (pt) 2008-10-14
IL182642A (en) 2012-10-31
RU2379289C2 (ru) 2010-01-20
AU2005298078B2 (en) 2011-03-31
HK1113364A1 (en) 2008-10-03
ZA200703996B (en) 2008-09-25
RU2007115888A (ru) 2008-11-10
TW200621709A (en) 2006-07-01
MX2007005126A (es) 2007-07-04
EP1806340A4 (en) 2009-08-12
CA2583660C (en) 2013-02-12
ES2362788T3 (es) 2011-07-13
BRPI0517515B8 (pt) 2021-05-25
WO2006046499A1 (ja) 2006-05-04
JP5049013B2 (ja) 2012-10-17
ATE508113T1 (de) 2011-05-15
KR20070084499A (ko) 2007-08-24
BRPI0517515B1 (pt) 2021-03-09
JPWO2006046499A1 (ja) 2008-05-22
CA2583660A1 (en) 2006-05-04
CN101048376B (zh) 2011-03-23
EP1806340B1 (en) 2011-05-04
US20070197627A1 (en) 2007-08-23
EP1806340A1 (en) 2007-07-11
IL182642A0 (en) 2007-07-24
DE602005027881D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
KR101249865B1 (ko) 인돌린 화합물 및 그 제조방법
EP2475634B1 (en) Process for the preparation of indoline derivatives and their intermediates thereof
WO2016180033A1 (zh) 一种前列环素受体激动剂的制备方法
US20140179922A1 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
JPH02180873A (ja) ４，５―ジクロロ―６―エチルピリミジンの製造方法
KR102674919B1 (ko) 3-브로모-5-(2-에틸이미다조[1,2-a]피리딘-3-카르보닐)-2-하이드록시벤조니트릴의 합성
CN115286491B (zh) 一种2-[2-(6-溴己氧基)乙氧基甲基]-1,3-二氯苯的制备方法
JP5305593B2 (ja) 高化学的ｒ−５−（２−（２−エトキシフェノキシエチルアミノ）プロピル）−２−メトキシベンゼンスルホンアミド塩酸塩の調製
JPH07304768A (ja) Ｎ−アルキル−ｎ−ピリジニル−１ｈ−インドール−１−アミンの製法
EP0713865B1 (fr) Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse
CN103328439B (zh) 氟代胺类的制造方法
HK1113364B (en) Indoline compound and process for producing the same
EP1566381B1 (en) Process for production of 1- 2-(benzimidazol-2-yl- thio)ethyl piperazine or salts thereof
JP4374088B2 (ja) 新規な４，４−ジフルオロベンゾアゼピンケタール誘導体、およびそれを経由する４，４−ジフルオロベンゾアゼピン−５−オン誘導体の製造方法
JPWO2017209035A1 (ja) ビフェニルベンズイミダゾール誘導体の製造方法
JP5414163B2 (ja) ５−｛４−［２−（５−エチル−２−ピリジル）エトキシ］ベンジル｝チアゾリジン−２，４−ジオン塩酸塩の製造方法
US20040116709A1 (en) Process for producing optically active n-aryl-1-amino-2-propanol derivatives
JPH1112265A (ja) ７−イソプロポキシイソフラボンの製造方法
CA2439208A1 (en) Process for producing optically active n-aryl-1-amino-2-propanol derivatives
JP2003055375A (ja) 光学活性ヒドラジン化合物の製造法
JPH07215968A (ja) アゼラスチンの製造方法
JP2001019676A (ja) 環状アミノ化合物の製造法
WO2011070419A1 (en) An improved process for the preparation of darifenacin hydrobromide
JPH0247469B2 (ja) Kogakukatsusei22*10*111jihidoroo100okisojibenzo*b*f*chepinn22iru**puropionsannorasemikahoho

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070523

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20101011

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120730

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20130220

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20130327

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20130328

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20160126

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20160126

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20170118

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20170118

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20180112

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20180112

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20181221

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20181221

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20200205

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20200205

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20201218

Start annual number: 9

End annual number: 13